Lucid Diagnostics Inc.
LUCDNASDAQHealthcare● Active
$0.96
$-0.01(-0.94%)
Market Cap$98017795
P/E Ratio—
52W High$1.629
52W Low$0.9
Lucid Diagnostics Inc. (LUCD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LUCD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.07
Est. -$0.05 · -40.0%
Revenue
$0.00B
Est. $0.00B · -9.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
LUCD reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.05 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.05 | -$0.07 | -40.0% | $0.00B | $0.00B | -9.0% |
| ▼ Q1 FY2026 | Mar 25, 2026 | -$0.07 | -$0.10 | -42.9% | $0.00B | $0.00B | +10.3% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.06 | -$0.10 | -66.7% | $0.00B | $0.00B | -12.7% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.09 | -$0.10 | -11.1% | $0.00B | $0.00B | -32.1% |
| ▼ Q2 FY2025 | May 14, 2025 | -$0.09 | -$0.16 | -77.8% | $0.00B | $0.00B | -46.3% |
| ▼ Q1 FY2025 | Mar 24, 2025 | -$0.15 | -$0.19 | -26.7% | $0.00B | $0.00B | -4.2% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$0.16 | -$0.20 | -25.0% | $0.00B | $0.00B | -17.7% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.07
EPS Est.
-$0.05
EPS Surpr.
-40.0%
Revenue
$0.00B
Q1 FY2026
Mar 25, 2026Miss
EPS Actual
-$0.10
EPS Est.
-$0.07
EPS Surpr.
-42.9%
Revenue
$0.00B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.06
EPS Surpr.
-66.7%
Revenue
$0.00B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.09
EPS Surpr.
-11.1%
Revenue
$0.00B
Q2 FY2025
May 14, 2025Miss
EPS Actual
-$0.16
EPS Est.
-$0.09
EPS Surpr.
-77.8%
Revenue
$0.00B
Q1 FY2025
Mar 24, 2025Miss
EPS Actual
-$0.19
EPS Est.
-$0.15
EPS Surpr.
-26.7%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$0.20
EPS Est.
-$0.16
EPS Surpr.
-25.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.05 | $-0.04 | $-0.03 | 1 |
| Q3 FY2027 | $-0.05 | $-0.04 | $-0.03 | 1 |
| Q2 FY2027 | $-0.06 | $-0.05 | $-0.04 | 1 |
| Q1 FY2027 | $-0.07 | $-0.06 | $-0.05 | 1 |
| Q4 FY2026 | $-0.06 | $-0.05 | $-0.04 | 1 |
| Q3 FY2026 | $-0.06 | $-0.05 | $-0.04 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -40.0% | $1.02 | $1.02 | +0.00% |
| ▼ Q1 FY2026 | Mar 25, 2026 | -42.9% | $1.20 | $1.19 | -0.83% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -66.7% | $1.04 | $1.11 | +6.73% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -11.1% | $1.00 | $0.98 | -1.64% |
| ▼ Q2 FY2025 | May 14, 2025 | -77.8% | $1.19 | $1.28 | +7.56% |
| ▼ Q1 FY2025 | Mar 24, 2025 | -26.7% | $1.52 | $1.50 | -1.32% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -25.0% | $1.00 | $1.05 | +5.00% |
| ▲ Q3 FY2024 | Aug 12, 2024 | +9.1% | $0.79 | $0.84 | +6.33% |
Q2 FY2026+0.00%
Report Date
May 14, 2026
EPS Beat/Miss
-40.0%
Price Before
$1.02
Price After
$1.02
Q1 FY2026-0.83%
Report Date
Mar 25, 2026
EPS Beat/Miss
-42.9%
Price Before
$1.20
Price After
$1.19
Q4 FY2025+6.73%
Report Date
Nov 12, 2025
EPS Beat/Miss
-66.7%
Price Before
$1.04
Price After
$1.11
Q3 FY2025-1.64%
Report Date
Aug 13, 2025
EPS Beat/Miss
-11.1%
Price Before
$1.00
Price After
$0.98
Q2 FY2025+7.56%
Report Date
May 14, 2025
EPS Beat/Miss
-77.8%
Price Before
$1.19
Price After
$1.28
Q1 FY2025-1.32%
Report Date
Mar 24, 2025
EPS Beat/Miss
-26.7%
Price Before
$1.52
Price After
$1.50
Q4 FY2024+5.00%
Report Date
Nov 13, 2024
EPS Beat/Miss
-25.0%
Price Before
$1.00
Price After
$1.05
Q3 FY2024+6.33%
Report Date
Aug 12, 2024
EPS Beat/Miss
+9.1%
Price Before
$0.79
Price After
$0.84
Avg Beat Reaction+6.33%
Avg Miss Reaction+2.21%
Beat Rate1 / 8 quarters
Largest Move+7.56% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LUCD ends December
Lucid Diagnostics Inc. (LUCD) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.07 — missing the analyst consensus of $-0.05 by -40.0%. The next LUCD earnings date is expected around September 1, 2026.
Each quarter, investors track LUCD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LUCD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LUCD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LUCD earnings · 5 questionsLucid Diagnostics Inc.'s next earnings report is expected around September 1, 2026. LUCD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LUCD historically reports after market close (AMC).
LUCD earnings datewhen is LUCD earningsLUCD next earnings datewhen does LUCD report earningsLUCD earnings calendar
▸ Source: FMP · Lucid Diagnostics Inc. SEC filings · US GAAP · Lucid Diagnostics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026